CTOs on the Move


 
Meet Twiage: An award-winning mobile communication technology that enables hospitals and EMS to accelerate life-saving emergency care by reducing the need of radio and phone communication. Twiage offers Hospitals & Emergency Departments: - Real-time prehospital clinical data for Stroke, STEMI, Trauma, and Sepsis, as well as all other EMS transports - HIPAA-compliant Videos, Photos, and EKGs - Patient Pre-Registration - GPS-tagged ETA for every incoming ambulance, optimizing ED flow and triage - Two-way communication capabilities for intra-hospital care coordination and inter-facility transfers. Twiage offers EMS: - Faster handoffs and ED turnaround times - No more reliance on radios! - HIPAA-compliant ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.twiagemed.com
  • 265 Canal St Suite 218
    New York, NY USA 10013
  • Phone: 646.863.5000

Executives

Name Title Contact Details

Similar Companies

World Congress

World Congress is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. World Congress is based in Woburn, MA. You can find more information on World Congress at www.worldcongress.com

Innovative Labs

Innovative Labs (IL) is a leading developer, formulator, and provider of single serve and multi-dose ingestible health and wellness products for leading brands and direct sales companies.

Mid-Atlantic Dental Partners

Mid-Atlantic Dental Partners delivers dental services through a partnership with dentists who are respected in their communities.

Lincoln County Ambulance District

Lincoln County Ambulance District is a Troy, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.